Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    Topscience Biotech specializes in R&D, production, and sales of Sodium Hyaluronate, focusing on Medical and Pharmaceutical Grade HA.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Menu

    Valiltramiprosate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alzheon To Present APOLLOE4 Ph3 Data At ADPD On April 1
    Alzheon To Present APOLLOE4 Ph3 Data At ADPD On April 1

    18 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250318710720/en/Alzheon-to-Present-Results-from-Pivotal-APOLLOE4-Phase-3-Trial-of-Oral-ValiltramiprosateALZ-801-at-Dedicated-Symposium-at-ADPD-Conference-in-Vienna-on-April-1st-2025

    BUSINESSWIRE
    18 Mar 2025
    Share Share
    Alzheon Publishes Two Papers Ahead Ph 3 Topline Data At ADPD
    Alzheon Publishes Two Papers Ahead Ph 3 Topline Data At ADPD

    25 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250225250957/en

    BUSINESSWIRE
    25 Feb 2025
    Share Share
    Anokion Presents ANK-700 Data For Multiple Sclerosis
    Anokion Presents ANK-700 Data For Multiple Sclerosis

    18 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240917374019/en

    BUSINESSWIRE
    18 Sep 2024
    Share Share
    Alzheon To Present ALZ-801 Trial Results At Alzheimer's Conference
    Alzheon To Present ALZ-801 Trial Results At Alzheimer's Conference

    23 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240723403529/en

    BUSINESSWIRE
    23 Jul 2024
    Share Share
    Alzheon Raises $100M Series E For Alzheimer's Drug Development
    Alzheon Raises $100M Series E For Alzheimer's Drug Development

    12 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240612246496/en

    BUSINESSWIRE
    12 Jun 2024
    Share Share
    Alzheon Doses First Patient In APOLLOE4 Extension, Launches Phase 2
    Alzheon Doses First Patient In APOLLOE4 Extension, Launches Phase 2

    30 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240430939765/en

    BUSINESSWIRE
    30 Apr 2024
    Share Share